Examining New Evidence and Advances in Multiple Myeloma

Examining New Evidence and Advances in Multiple Myeloma

Dr. Andrzej Jakubowiak, professor of medicine, discusses the results of the recent phase III trials and how they impact the current standards of treatment of newly diagnosed myeloma.  Dr. Jakubowiak also evaluates the role of transplant and post-transplant treatment in the context of recent clinical trials.    


Published

September 7, 2016

Created by

The University of Chicago Medicine

Related Presenters

Jakubowiak

Andrzej Jakubowiak, MD

Professor of Medicine

Andrzej Jakubowiak, MD, PhD, is an internationally known expert on multiple myeloma, a cancer of the plasma cells in a patient’s bone marrow. He works closely with the Multiple Myeloma Research Consortium (MMRC) to bring the latest ...